Cubist Systematic Strategies, LLC Acelrx Pharmaceuticals Inc Transaction History

Cubist Systematic Strategies, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$1.66 - $2.4 $55,942 - $80,880	-33,700 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.1 - $2.87 $8,190 - $11,193	-3,900 Reduced 10.37%	33,700 $74,000
Q2 2019 Aug 14, 2019	BUY	$2.1 - $3.93 $78,960 - $147,768	37,600 New	37,600 $95,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.